Celltrion: Biosimilar new product sales expand; target price up 11% - NH
Predicted impact: Medium
Record quarterly revenue and target price raised 11%; meaningful but smaller than a major surprise.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.